Updated Jul 16, 2026
Randhawa Simrat has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $12.54M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | DNTH | Dianthus Therapeutics, Inc. /DE/ | S — Open-market sale | 4.2K | $91.37 | $380K |
| 2026-06-02 | DNTH | Dianthus Therapeutics, Inc. /DE/ | S — Open-market sale | 16.9K | $90.72 | $1.54M |
| 2026-06-02 | DNTH | Dianthus Therapeutics, Inc. /DE/ | S — Open-market sale | 5.4K | $89.72 | $487K |
| 2026-06-02 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise | 9.4K | $22.07 | $207K |
| 2026-06-02 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise | 6.2K | $21.77 | $136K |
| 2026-06-02 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise | 6.9K | $17.88 | $124K |
| 2026-06-02 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise | 4.0K | $8.44 | $34K |
| 2026-03-14 | DNTH | Dianthus Therapeutics, Inc. /DE/ | S — Open-market sale [10b5-1] | 33.8K | $81.48 | $2.76M |
| 2026-03-14 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise [10b5-1] | 12.5K | $22.07 | $276K |
| 2026-03-14 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise [10b5-1] | 8.3K | $21.77 | $181K |
| 2026-03-14 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise [10b5-1] | 5.0K | $17.88 | $89K |
| 2026-03-14 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise [10b5-1] | 8.0K | $8.44 | $68K |
| 2025-11-15 | DNTH | Dianthus Therapeutics, Inc. /DE/ | S — Open-market sale | 109.0K | $38.14 | $4.16M |
| 2025-11-15 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise | 31.2K | $22.07 | $690K |
| 2025-11-15 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise | 37.5K | $21.77 | $816K |
| 2025-11-15 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise | 40.3K | $17.88 | $720K |
| 2025-11-15 | DNTH | Dianthus Therapeutics, Inc. /DE/ | S — Open-market sale | 18.6K | $37.72 | $701K |
| 2025-11-15 | DNTH | Dianthus Therapeutics, Inc. /DE/ | S — Open-market sale | 42.8K | $37.04 | $1.58M |
| 2025-11-15 | DNTH | Dianthus Therapeutics, Inc. /DE/ | S — Open-market sale | 26.2K | $35.80 | $937K |
| 2025-11-15 | DNTH | Dianthus Therapeutics, Inc. /DE/ | M — Option exercise | 3.5K | $17.88 | $63K |
Randhawa Simrat is a corporate insider — currently tracked as Insider of Dianthus Therapeutics, Inc. /DE/ (DNTH). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($12.54M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Randhawa Simrat profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.